{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:29:18Z","timestamp":1762104558596,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.anai.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:51:59Z","timestamp":1715939519000},"page":"219-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiple reactions during desensitization and predicting decreased efficacy of pegaspargase chemotherapy"],"prefix":"10.1016","volume":"133","author":[{"given":"Elizabeth A.","family":"Gilje","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2024.05.009_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.902117","article-title":"Current use of asparaginase in acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"10","author":"Maese","year":"2022","journal-title":"Front Pediatr"},{"issue":"17","key":"10.1016\/j.anai.2024.05.009_bib0002","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.anai.2024.05.009_bib0003","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41375-024-02153-6","article-title":"Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia","volume":"38","author":"Dam","year":"2024","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.anai.2024.05.009_bib0004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1043454217741868","article-title":"Clinical characteristics of intravenous PEG-asparaginase hypersensitivity reactions in patients undergoing treatment for acute lymphoblastic leukemia","volume":"35","author":"Browne","year":"2018","journal-title":"J Pediatr Oncol Nurs"},{"issue":"5","key":"10.1016\/j.anai.2024.05.009_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/08880018.2019.1634778","article-title":"Pegylated E. coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability","volume":"36","author":"Verma","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.009_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.2019003407","article-title":"Predicting success of desensitization after pegaspargase allergy","volume":"135","author":"Swanson","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anai.2024.05.009_bib0007","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1097\/MPH.0000000000002241","article-title":"Tolerability and efficacy of a 1-bag pegaspargase densensitization protocol in pediatric oncology patients","volume":"44","author":"Cramer","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.009_bib0008","doi-asserted-by":"crossref","first-page":"e28021","DOI":"10.1002\/pbc.28021","article-title":"Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"67","author":"August","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.anai.2024.05.009_bib0009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.anai.2019.11.001","article-title":"A 12-steps desensitization protocol for pediatric patients with hypersensitivity to pegylated asparaginase","volume":"124","author":"Concha","year":"2020","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624002928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624002928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T23:06:28Z","timestamp":1722553588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624002928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1081120624002928"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.05.009","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple reactions during desensitization and predicting decreased efficacy of pegaspargase chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}